Historical event: 14 January 2025. Sources and calculator scope checked on 11 November 2026. This article explains a Commission proposal, not universally adopted diagnostic rules.
On 14 January 2025, a Commission in The Lancet Diabetes & Endocrinology published a proposed definition and diagnostic criteria for clinical obesity. Its question was how to distinguish a risk of future illness from illness already affecting a person. The publication record confirms the online date; the journal issue was March 2025.
Two categories with different meanings
The Commission proposed assessing excess body fat together with its effects on health. Under its framework, clinical obesity involves impaired organ or tissue function, or substantial age-adjusted limitations in daily activities, caused by excess adiposity. Preclinical obesity describes excess body fat with preserved organ and tissue function and without substantial related limitations in daily activities. Future health risks are generally increased, but vary between people. It is not simply another name for the adult overweight BMI category.
The distinction is about assessment and care. A person in the proposed preclinical category may still need monitoring and help to reduce risk. Someone with clinical obesity needs assessment of the illness and appropriate treatment. Neither term is a judgment about effort, character or how a person looks.
King’s College London’s explanation on 29 January 2025 described the recommendations as recently proposed and highlighted the use of measurements beyond BMI and objective evidence of disease. That later explanation provides context; it is not the publication date of the Commission itself.
Why the assessment cannot stop at BMI
The Commission retained a role for BMI in screening and population research. For most individual assessments, it recommended confirming excess body fat with another validated body measurement, or measuring body fat directly where available. The proposal allows an exception when BMI is above 40: excess body fat can be assumed without another confirming measurement. That still does not, by itself, establish clinical obesity. The framework also assesses whether excess body fat is causing relevant health problems or substantial limitations. Establishing that connection requires clinical judgment.
In everyday terms, three different questions need separating: what is the person’s weight relative to height, is there excess body fat, and is that excess fat causing illness? An online BMI calculation answers only the first. It cannot examine organs, evaluate the causes of symptoms or determine whether a limitation meets the proposed criteria.
What a calculator can still contribute
For example, an adult weighing 90 kg (about 198 lb) at 1.70 m (about 5 ft 7 in) has a BMI of 90 ÷ (1.70 × 1.70), about 31.1 kg/m². The adult BMI calculator places this in the WHO adult obesity screening category. The tool is available for adults aged 18 and over; it does not implement the Commission’s diagnostic assessment.
That example cannot tell us whether this hypothetical person would meet the proposed clinical or preclinical definition. Adding a label based only on 31.1 would skip the assessment the proposal calls for. Likewise, a result below an obesity BMI cutoff cannot by itself rule out a health concern that deserves attention.
Questions to take into care
- What does my BMI add to the assessment, and what does it leave uncertain?
- Would another measurement provide useful information?
- Are symptoms or limitations being assessed on their own merits?
- Which clinical guidance is being used for decisions about my care?
A consensus proposal does not automatically replace national guidelines, local services or insurance rules. Do not assume that a familiar BMI category has disappeared, or that treatment access has changed because the paper was published. Use the proposal to understand why a fuller assessment matters, and discuss your own symptoms and circumstances with a qualified health professional.
Leave a Reply